1. Patent Highlights: Recently Approved HCV NS5a Drugs
2. Information on synthetic routes to approved drugs, including patents and journal publications, can be found on the web sites of Pharmacodia (http://www.pharmacodia.com/en) and Anthony Crasto (https://newdrugapprovals.org/author/amcrasto/). (accessed Oct 3, 2016) .
3. The “tinib” suffix is reserved for tyrosine kinase inhibitors.http://druginfo.nlm.nih.gov/drugportal/jsp/drugportal/DrugNameGenericStems.jsp(accessed Sep 4, 2016) .
4. http://www.prnewswire.com/news-releases/celera-genomics-announces-sale-of-therapeutic-programs-to-pharmacyclics-56115072.html(accessed Sep 4, 2016) .
5. http://wxpress.wuxiapptec.com/wuxi-partner-pharmacyclics/(accessed Sep 4, 2016) .